Cargando…
Efalizumab in the Treatment of Scalp, Palmoplantar and Nail Psoriasis: Results of a 24-Week Latin American Study
INTRODUCTION: Plaque-type psoriasis affecting the nails, scalp, hands or feet can often be difficult to treat; for example, topical treatments and phototherapy may not penetrate the nail plate or scalp. The objective of this large, international, multicentre study was to investigate the efficacy of...
Autores principales: | Takahashi, María Denise, Chouela, Edgardo Néstor, Dorantes, Gladys Leon, Roselino, Ana Maria, Santamaria, Jesùs, Allevato, Miguel Angel, Cestari, Tania, de Aillaud, Maria Eugenia Manzanera, Stengel, Fernando Miguel, Licu, Daiana |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Inc
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2855826/ https://www.ncbi.nlm.nih.gov/pubmed/20428227 http://dx.doi.org/10.1111/j.1753-5174.2009.00025.x |
Ejemplares similares
-
Control of Moderate-to-Severe Plaque Psoriasis with Efalizumab: 24-Week, Open-Label, Phase IIIb/IV Latin American Study Results
por: Stengel, Fernando M, et al.
Publicado: (2009) -
Assessing the Impact of Efalizumab on Nail, Scalp and Palmoplantar Psoriasis and on Quality of Life: Results from a Multicentre, Open-label, Phase IIIb/IV Trial
por: Katsambas, Andreas, et al.
Publicado: (2009) -
Efficacy of Tildrakizumab for the Treatment of Difficult-to-Treat Areas: Scalp, Nail, Palmoplantar and Genital Psoriasis
por: Galluzzo, Marco, et al.
Publicado: (2022) -
Efalizumab in the treatment of psoriasis
por: Boehncke, Wolf-Henning
Publicado: (2007) -
Efficacy and Safety of Efalizumab in Patients with Moderate-to-Severe Plaque Psoriasis Resistant to Previous Anti-Psoriatic Treatment: Results of a Multicentre, Open-label, Phase IIIb/IV Trial
por: Lotti, Torello, et al.
Publicado: (2010)